Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
12 Aug 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
18 Dec 23
8-K
Miromatrix Reports Third Quarter 2023 Results
14 Nov 23
8-K
Tender and Support Agreement
30 Oct 23
8-K
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 23
8-K
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D
1 Jun 23
8-K
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
11 May 23
8-K
Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
31 Mar 23
8-K
Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
8 Mar 23
8-K
Miromatrix Provides Update on miroliverELAP
1 Feb 23
Registration and prospectus
15-12G
Securities registration termination
26 Dec 23
POS AM
Prospectus update (post-effective amendment)
13 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 23
SC 14D9/A
Tender offer solicitation (amended)
13 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
13 Dec 23
25-NSE
Exchange delisting
13 Dec 23
SC 14D9/A
Tender offer solicitation (amended)
12 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
12 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
4 Dec 23
Other
EFFECT
Notice of effectiveness
18 Dec 23
CORRESP
Correspondence with SEC
12 Dec 23
UPLOAD
Letter from SEC
11 Dec 23
CORRESP
Correspondence with SEC
30 Nov 23
UPLOAD
Letter from SEC
22 Nov 23
UPLOAD
Letter from SEC
22 Nov 23
EFFECT
Notice of effectiveness
12 Jul 22
EFFECT
Notice of effectiveness
24 Jun 21
CERT
Certification of approval for exchange listing
23 Jun 21
CORRESP
Correspondence with SEC
22 Jun 21
Ownership
SC 13G/A
DAVITA INC.
14 Feb 24
SC 13G/A
LYTTON LAURENCE W
14 Feb 24
SC 13D
UNITED THERAPEUTICS Corp
22 Dec 23
3
Initial statement of insider ownership
14 Dec 23
4
Lisa Wipperman Heine
13 Dec 23
4
Peter Maag
13 Dec 23
4
JOHN L ERB
13 Dec 23
4
PAUL BUCKMAN
13 Dec 23
4
William P. Mr. Burke
13 Dec 23
4
James Michael Douglas
13 Dec 23